Detalhe da pesquisa
1.
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer.
N Engl J Med
; 384(25): 2394-2405, 2021 06 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-34081848
2.
Patient-Reported Financial Burden of Treatment for Colon or Rectal Cancer.
JAMA Netw Open
; 7(1): e2350844, 2024 Jan 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38194233
3.
Validation of Immunotherapy Response Score as Predictive of Pan-solid Tumor Anti-PD-1/PD-L1 Benefit.
Cancer Res Commun
; 3(7): 1335-1349, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37497337
4.
Phase II Study of Copanlisib in Patients With Tumors With PIK3CA Mutations: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1F.
J Clin Oncol
; 40(14): 1552-1561, 2022 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133871
5.
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
J Clin Oncol
; 40(3): 282-293, 2022 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34874182
6.
Randomized Phase II Study of PARP Inhibitor ABT-888 (Veliparib) with Modified FOLFIRI versus FOLFIRI as Second-line Treatment of Metastatic Pancreatic Cancer: SWOG S1513.
Clin Cancer Res
; 27(23): 6314-6322, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34580114
7.
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples.
JCO Precis Oncol
; 52021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34476329
8.
Assessment of Treatment With Sorafenib Plus Doxorubicin vs Sorafenib Alone in Patients With Advanced Hepatocellular Carcinoma: Phase 3 CALGB 80802 Randomized Clinical Trial.
JAMA Oncol
; 5(11): 1582-1588, 2019 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486832
9.
Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer.
JCO Oncol Pract
; 18(9): 636-644, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35700421